InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ENANTA PHARMACEUTICALS INC

ENTA Clue Score19
United States Fiscal year ends September CIK 0001177648 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Jay R. Luly
5 Dec 2025
President and CEO
Sell
4,743
$14.23
$67.49K
Yat Sun Or
5 Dec 2025
Chief Scientific Officer
Sell
2,390
$14.23
$34.01K
Tara Lynn Kieffer
5 Dec 2025
Chief Product Strategy Officer
Sell
2,106
$14.23
$29.97K
Brendan Luu
5 Dec 2025
Chief Business Officer
Sell
1,394
$14.23
$19.84K
Scott T. Rottinghaus
5 Dec 2025
Chief Medical Officer
Sell
798
$14.23
$11.36K
Harry R. Trout III
5 Dec 2025
See Remarks
Sell
542
$14.23
$7.71K
Kathleen S. Capps
5 Dec 2025
See Remarks
Sell
323
$14.23
$4.60K
Harry R. Trout III
2 Dec 2025
See Remarks
Sell
380
$13.96
$5.30K
Kathleen S. Capps
2 Dec 2025
See Remarks
Sell
207
$13.96
$2.89K

What was left out

Form 4 filings counted 34
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 88,936
History held since 22 Mar 2013